Regenxbio (RGNX) Other Gross PP&E Adjustments (2016 - 2025)
Regenxbio (RGNX) has 11 years of Other Gross PP&E Adjustments data on record, last reported at $144.9 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 6.41% year-over-year to $144.9 million; the TTM value through Dec 2025 reached $144.9 million, up 6.41%, while the annual FY2025 figure was $144.9 million, 6.41% up from the prior year.
- Other Gross PP&E Adjustments reached $144.9 million in Q4 2025 per RGNX's latest filing, up from $142.2 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $144.9 million in Q4 2025 and bottomed at $51.3 million in Q1 2021.
- Average Other Gross PP&E Adjustments over 5 years is $118.7 million, with a median of $127.2 million recorded in 2023.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 5285.69% in 2021, then grew 5.05% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $99.7 million in 2021, then increased by 18.34% to $118.0 million in 2022, then rose by 9.21% to $128.8 million in 2023, then grew by 5.7% to $136.2 million in 2024, then increased by 6.41% to $144.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $144.9 million in Q4 2025, $142.2 million in Q3 2025, and $140.6 million in Q2 2025.